Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer.
about
Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Repurposing tin mesoporphyrin ...... preclinical models of cancer.
@en
Repurposing tin mesoporphyrin ...... preclinical models of cancer.
@nl
type
label
Repurposing tin mesoporphyrin ...... preclinical models of cancer.
@en
Repurposing tin mesoporphyrin ...... preclinical models of cancer.
@nl
prefLabel
Repurposing tin mesoporphyrin ...... preclinical models of cancer.
@en
Repurposing tin mesoporphyrin ...... preclinical models of cancer.
@nl
P2093
P2860
P50
P1476
Repurposing tin mesoporphyrin ...... preclinical models of cancer.
@en
P2093
Andrew Tutt
Cheryl E Gillett
James N Arnold
Jonathan Caron
Mary Okesola
Mieke Van Hemelrijck
Paris Kosti
Sandra S Diebold
Sharanpreet Lall
Stephen F Madden
P2860
P304
P356
10.1158/1078-0432.CCR-17-2587
P407
P577
2018-01-16T00:00:00Z